Regulatory RNAs and paracrine networks in the heart

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 290-301

  Viereck, Janika ^a   Bang, Claudia ^a   Foinquinos, Ariana ^a   Thum, Thomas ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac fibroblast; Cardiac remodelling; Cardiomyocyte; MicroRNAs; Paracrine communication; Therapeutics

Indexed keywords

ANGIOTENSIN II; GROWTH FACTOR; INTERLEUKIN DERIVATIVE; MICRORNA; NATRIURETIC FACTOR; RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL COMMUNICATION; FIBROBLAST; GENE CONTROL; HEART FAILURE; HEART MUSCLE CELL; HUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; ANIMAL; CARDIOMEGALY; FIBROSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOMEGALY; FIBROSIS; HEART FAILURE; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION;

EID: 84899121027     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu039     Document Type: Review

References (197)

1. Kuwahara K Nishikimi T Nakao K. Transcriptional regulation of the fetal cardiac gene program. J Pharmacol Sci 2012;119:198-203
2. Burchfield JS XieM Hill JA. Pathological ventricular remodeling: Mechanisms: Part 1 of Circulation 2013;128:388-400
3. Bowers SL Baudino TA.Cardiac myocyte-fibroblast interactions and the coronary vasculature. J Cardiovasc Transl Res 2012;5:783-793
4. Martin ML Blaxall BC. Cardiac intercellular communication: Are myocytes and fibroblasts fair-weather friends?. J Cardiovasc Transl Res 2012;5:768-782
5. Zhang P Su J Mende U. Cross talk between cardiac myocytes and fibroblasts: From multiscale investigative approaches to mechanisms and functional consequences. Am J Physiol Heart Circ Physiol 2012;303:H1385-H1396
6. Takeda N Manabe I. Cellular interplay between cardiomyocytes and nonmyocytes in cardiac remodeling. Int J Inflam 2011;2011:535241
7. Manabe I Shindo T Nagai R. Gene expression in fibroblasts and fibrosis: Involvement in cardiac hypertrophy. Circ Res 2002;91:1103-1113
8. Bowers SL Banerjee I Baudino TA. The extracellular matrix: At the center of it all. J Mol Cell Cardiol 2010;48:474-482
9. Rohr S. Arrhythmogenic implications of fibroblast-myocyte interactions. Circ Arrhythm Electrophysiol 2012;5:442-452
10. Chen X Liang H Zhang J Zen K Zhang CY. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 2012;22:125-132
11. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-355
12. Bartel DP. MicroRNAs: Genomics biogenesis mechanism and function. Cell 2004;116: 281-297
13. Xin M Olson EN Bassel-Duby R. Mending broken hearts: Cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol 2013;14:529-541
14. Boettger T Braun T. A new level of complexity: The role of microRNAs in cardiovascular development. Circ Res 2012;110:1000-1013
15. Gladka MM da Costa Martins PA De Windt LJ. Small changes can make a big difference- microRNA regulation of cardiac hypertrophy. J Mol Cell Cardiol 2012;52:74-82
16. Kumarswamy R Thum T. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res 2013;113:676-689
17. Tijsen AJ Pinto YM Creemers EE. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res 2012;93:573-582
18. Vettori S Gay S Distler O. Role of microRNAs in fibrosis. Open Rheumatol J 2012;6: 130-139
19. Adam O Lohfelm B Thum T Gupta SK Puhl SL Schafers HJ et al. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol 2012;107:278
20. Jeppesen PL Christensen GL Schneider M NossentAY Jensen HB AndersenDCet al. Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. Br J Pharmacol 2011;164:394-404
21. Pan Z Sun X Shan HWang NWang J Ren J et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation 2012;126:840-850
22. Jiang X NingQWang J. Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts. J Physiol Sci 2013;63:31-38
23. Curcio A Torella D Iaconetti C Pasceri E Sabatino J Sorrentino S et al. MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS ONE 2013;8:e70158
24. Cheng Y Ji R Yue J Yang J Liu X ChenH et al. MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy?. Am J Pathol 2007;170: 1831-1840
25. XuXD SongXW LiQWang GK Jing Q QinYW. Attenuation of microRNA-22 derepressedPTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol 2012;227:1391-1398
26. PanW Zhong Y Cheng C Liu BWang L Li A et al. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS ONE 2013;8:e53950
27. Ucar A Gupta SK Fiedler J Erikci E Kardasinski M Batkai S et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 2012;3:1078
28. Thum T Gross C Fiedler J Fischer T Kissler S Bussen M et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984
29. Liang H Zhang C Ban T Liu Y Mei L Piao X et al. A novel reciprocal loop between microRNA-21 and TGFbetaRIII is involved in cardiac fibrosis. Int J Biochem Cell Biol 2012;44:2152-2160
30. Wang J HuangW Xu R Nie Y Cao X Meng J et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 2012;16:2150-2160
31. van Rooij E Sutherland LB Thatcher JE DiMaio JM Naseem RH MarshallWSet al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008;105:13027-13032
32. Wang J SongY ZhangY Xiao H Sun QHouNet al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2012;22: 516-527
33. Shan H Zhang Y Lu Y Zhang Y Pan Z Cai B et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009;83:465-472
34. Wang BWWu GJ Cheng WP Shyu KG. Mechanical stretch via transforming growth factor-beta1 activates microRNA-208a to regulate hypertrophy in cultured rat cardiac myocytes. J Formos Med Assoc 2013;112:635-643
35. Duisters RF Tijsen AJ Schroen B Leenders JJ Lentink V van Der Made I et al. miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of micro-RNAs in myocardial matrix remodeling. Circ Res 2009;104:170-178 6p following 178
36. Abonnenc M Nabeebaccus AA Mayr U Barallobre-Barreiro J Dong X Cuello F et al. Extracellular matrix secretion by cardiac fibroblasts: Role of microRNA-29b and microRNA-30c. Circ Res 2013;113:1138-1147
37. Kwiecinski M Elfimova N Noetel A Tox U Steffen HM Hacker U et al. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Lab Invest 2012;92:978-987
38. Yu XY Song YH Geng YJ Lin QX Shan ZX Lin SG et al. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem Biophys Res Commun 2008;376: 548-552
39. Elia L Contu R Quintavalle M Varrone F Chimenti C RussoMAet al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 2009;120:2377-2385
40. Li D He B Zhang H Shan SF Liang Q Yuan WJ et al. The inhibitory effect of miRNA-1 on ET-1 gene expression. FEBS Lett 2012;586:1014-1021
41. Wang K Lin ZQ Long B Li JH Zhou J Li PF.Cardiac hypertrophy is positively regulated by microRNA miR-23a. J Biol Chem 2012;287:589-599
42. Eskildsen TV Jeppesen PL Schneider M Nossent AY Sandberg MB Hansen PB et al. Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci 2013;14:11190-11207
43. Wang X Ha T Liu L Zou J Zhang X Kalbfleisch J et al. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res 2013;97:432-442
44. Zgheib C Zouein FA Kurdi M Booz GW. Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function. Eur Cytokine Netw 2012;23:191-197
45. Valente AJ Yoshida T Gardner JD Somanna N Delafontaine P Chandrasekar B. Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell Signal 2012;24: 560-568
46. Yeh CH Chen TPWang YC Lin YM Fang SW. MicroRNA-27a regulates cardiomyocytic apoptosis during cardioplegia-induced cardiac arrest by targeting interleukin 10-related pathways. Shock 2012;38:607-614
47. Sowa N Horie T Kuwabara Y Baba O Watanabe S Nishi H et al. MicroRNA 26b encoded by the intron of small CTD phosphatase (SCP) 1 has an antagonistic effect on its host gene. J Cell Biochem 2012;113:3455-3465
48. Bernardo BC Gao XM Winbanks CE Boey EJ Tham YK Kiriazis H et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 2012;109:17615-17620
49. Arora P Wu C Khan AM Bloch DB Davis-Dusenbery BN Ghorbani A et al. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest 2013;123: 3378-3382
50. Sadoshima J Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993;73:413-423
51. Pathak M Sarkar S Vellaichamy E Sen S. Role of myocytes in myocardial collagen production. Hypertension 2001;37:833-840
52. Harada K Komuro I Zou Y Kudoh S Kijima K MatsubaraHet al. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. Circ Res 1998;82:779-785
53. Harada K Komuro I Shiojima I Hayashi D Kudoh S Mizuno T et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 1998;97:1952-1959
54. Gray MO Long CS Kalinyak JE Li HT Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998;40:352-363
55. Lopez JJ Lorell BH Ingelfinger JRWeinberg EO Schunkert H Diamant D et al. Distribution and function of cardiac angiotensin AT1- And AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994;267:H844-H852
56. Suzuki J Matsubara H Urakami M Inada M. Rat angiotensin II (type 1A) receptormRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993;73:439-447
57. Tsutsumi Y MatsubaraH Ohkubo N Mori Y Nozawa Y Murasawa S et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998;83:1035-1046
58. Everett AD Tufro-McReddie A Fisher A Gomez RA. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 1994;23:587-592
59. SchorbW Booz GW Dostal DE Conrad KM Chang KC Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 1993;72:1245-1254
60. Li Y Li XH Yuan H. Angiotensin II type-2 receptor-specific effects on the cardiovascular system. Cardiovasc Diagn Ther 2012;2:56-62
61. Wada H Zile MR IvesterCT CooperGIV McDermott PJ. Comparative effects of contraction and angiotensin II on growth of adult feline cardiocytes in primary culture. Am J Physiol 1996;271:H29-H37
62. Harada M Itoh H Nakagawa O OgawaY MiyamotoY KuwaharaK et al. Significance of ventricular myocytes and nonmyocytes interaction During cardiocyte hypertrophy: Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 1997;96:3737-3744
63. Kawano HDoYS Kawano Y StarnesV Barr M Law RE et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000;101:1130-1137
64. Sano M Fukuda K Kodama H Pan J Saito M Matsuzaki J et al. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 2000;275:29717-29723
65. Dobaczewski M ChenW Frangogiannis NG. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 2011;51:600-606
66. Lee AA Dillmann WH McCulloch AD Villarreal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27:2347-2357
67. Takahashi N Calderone A Izzo NJ Jr Maki TM Marsh JD Colucci WS. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J Clin Invest 1994;94:1470-1476
68. Engelmann GL Grutkoski PS. Coordinate TGF-beta receptor gene expression During rat heart development. Cell Mol Biol Res 1994;40:93-104
69. Creemers EE Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011;89:265-272
70. Desmouliere A Geinoz A Gabbiani F Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-111
71. Lijnen P Petrov V. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol 2002;24:333-344
72. Chua CC Chua BH Zhao ZY Krebs C Diglio C Perrin E. Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 1991;26: 271-281
73. Davis BN Hilyard AC Lagna G Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008;454:56-61
74. Zhou LWang L Lu L Jiang P Sun HWang H. Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes transdifferentiation of mouse myoblasts into myofibroblasts. PLoS ONE 2012;7:e33766
75. Kumarswamy R Volkmann I Jazbutyte V Dangwal S Park DH Thum T. Transforming growth factor-beta-induced endothelial-To-mesenchymal transition is partly mediated by microRNA-21. Arterioscler Thromb Vasc Biol 2012;32:361-369
76. Schultz Jel J Witt SA Glascock BJ Nieman ML Reiser PJ Nix SL et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 2002;109:787-796
77. Divakaran V Adrogue J Ishiyama M Entman ML Haudek S Sivasubramanian N et al. Adaptive and maladaptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2009;2:633-642
78. Xu J Kimball TR Lorenz JN Brown DA Bauskin AR Klevitsky R et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006;98:342-350
79. Yoon PO Lee MA ChaH Jeong MH Kim J Jang SP et al. The opposing effects ofCCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 2010;49:294-303
80. Leask A Abraham DJ. The role of connective tissue growth factor a multifunctional matricellular protein in fibroblast biology. Biochem Cell Biol 2003;81:355-363
81. Chen MM Lam A Abraham JA Schreiner GF Joly AH. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis. J Mol Cell Cardiol 2000;32:1805-1819
82. Virag JA Rolle ML Reece J Hardouin S Feigl EO Murry CE. Fibroblast growth factor-2 regulates myocardial infarct repair: Effects on cell proliferation scar contraction and ventricular function. Am J Pathol 2007;171:1431-1440
83. House SL House BE Glascock B Kimball T Nusayr E Schultz JE et al. Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through activation of the extracellular regulated kinase. Mol Cell Pharmacol 2010;2:143-154
84. Kardami E Liu L Pasumarthi SK Doble BW Cattini PA. Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. Ann N Y Acad Sci 1995;752: 353-369
85. Cummins P. Fibroblast and transforming growth factor expression in the cardiac myocyte. Cardiovasc Res 1993;27:1150-1154
86. Liao S Bodmer J Pietras D Azhar M Doetschman T Schultz Jel J. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev Dyn 2009;238:249-264
87. Bogoyevitch MA Glennon PE Andersson MB Clerk A Lazou A Marshall CJ et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-Activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 1994;269:1110-1119
88. Kaye D Pimental D Prasad S Maki T Berger HJ McNeil PL et al. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest 1996;97:281-291
89. Aoyama T Takimoto Y Pennica D Inoue R Shinoda E Hattori R et al. Augmented expression of cardiotrophin-1 and its receptor component gp130 in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 2000;32:1821-1830
90. Takeda N Manabe I Uchino Y Eguchi K Matsumoto S Nishimura S et al.Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 2010;120:254-265
91. Horio T Maki T Kishimoto I Tokudome T Okumura H Yoshihara F et al. Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts. Regul Pept 2005;124:65-72
92. Blaauw E van Nieuwenhoven FA Willemsen P Delhaas T Prinzen FW Snoeckx LH et al. Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 2010;299:H780-H787
93. Hu BS Landeen LK Aroonsakool N Giles WR. An analysis of the effects of stretch on IGF-I secretion from rat ventricular fibroblasts. Am J Physiol Heart Circ Physiol 2007;293: H677-H683
94. Li X Ponten A Aase K Karlsson L Abramsson A Uutela M et al. PDGF-C is a new protease-Activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000;2:302-309
95. Ponten A Li X Thoren P Aase K Sjoblom T Ostman A et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis hypertrophy and dilated cardiomyopathy. Am J Pathol 2003;163:673-682
96. Ponten A Folestad EB Pietras K Eriksson U. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res 2005;97:1036-1045
97. Shindo T Manabe I FukushimaY Tobe K Aizawa K Miyamoto S et al. Kruppel-like zincfinger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 2002;8:856-863
98. ZhaoW Zhao T Huang V Chen Y Ahokas RA Sun Y. Platelet-derived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol 2011;51: 830-838
99. Zhao T ZhaoW Chen Y Li VS MengW Sun Y. Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2013;304: H1719-H1726
100. Accornero F van Berlo JH Benard MJ Lorenz JN Carmeliet P Molkentin JD. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 2011;109:272-280
101. Shi-wen X Kennedy L Renzoni EA Bou-Gharios G du Bois RM Black CM et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 2007;56:4189-4194
102. Adiarto S Heiden S Vignon-Zellweger N Nakayama K Yagi K YanagisawaMet al. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. Life Sci 2012;91:651-657
103. Hawkins HK Entman ML Zhu JY Youker KA Berens K DoreMet al. Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody. Am J Pathol 1996;148:1957-1969
104. Neumann FJ Ott I Gawaz M Richardt G Holzapfel H JochumMet al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-755
105. van De Vrie M Heymans S Schroen B. MicroRNA involvement in immune activation During heart failure. Cardiovasc Drugs Ther 2011;25:161-170
106. Maass DL Hybki DP White J Horton JW. The time course of cardiac NF-kappaB activation and TNF-Alpha secretion by cardiac myocytes after burn injury: Contribution to burn-related cardiac contractile dysfunction. Shock 2002;17:293-299
107. Bader T Weitzerbin J. Nuclear accumulation of interferon gamma. Proc Natl Acad Sci USA 1994;91:11831-11835
108. Giroir BP Horton JW White DJ McIntyre KL Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction During burn shock. Am J Physiol 1994;267: H118-H124
109. Yokoyama T Sekiguchi K Tanaka T Tomaru K Arai M Suzuki Tet al. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol 1999;276:H1968-H1976
110. LaFramboise WA Scalise D Stoodley P Graner SR Guthrie RD Magovern JA et al. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am J Physiol Cell Physiol 2007;292:C1799-C1808
111. Sarkar S Vellaichamy E Young D Sen S. Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: Role of myocytes. Am J Physiol Heart Circ Physiol 2004;287:H107-H117
112. Bowers SL Borg TK Baudino TA. The dynamics of fibroblast-myocyte- capillary interactions in the heart. Ann N Y Acad Sci 2010;1188:143-152
113. Micheau O Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-190
114. Krown KA Yasui K Brooker MJ Dubin AE Nguyen C Harris GL et al. TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-Type Ca2+ current and Ca2+ transients. FEBS Lett 1995;376:24-30
115. Sivasubramanian N Coker ML Kurrelmeyer KM MacLellan WR DeMayo FJ Spinale FG et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001;104:826-831
116. Kubota T McTiernan CF Frye CS Demetris AJ Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-Alpha causes lethal myocarditis in transgenic mice. J Card Fail 1997;3:117-124
117. Porter KE Turner NA ORegan DJ Ball SG. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation invasion and MMP-9 secretion: Inhibition by simvastatin. Cardiovasc Res 2004;64:507-515
118. Awad AE Kandalam V Chakrabarti SWang X Penninger JM Davidge ST et al. Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependentmanner.AmJ Physiol Cell Physiol 2010;298:C679-C692
119. Nian M Lee P Khaper N Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-1553
120. Bujak M Dobaczewski M Chatila K Mendoza LH Li N Reddy A et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008;173:57-67
121. Cain BS Meldrum DR Dinarello CA Meng X Joo KS Banerjee A et al. Tumor necrosis factor-Alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 1999;27:1309-1318
122. Honsho S Nishikawa S Amano K Zen K Adachi Y Kishita E et al. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ Res 2009;105:1149-1158
123. Souders CA Bowers SL Baudino TA. Cardiac fibroblast: The renaissance cell. Circ Res 2009;105:1164-1176
124. Mitchell MD Laird RE Brown RD Long CS. IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. Am J Physiol Heart Circ Physiol 2007;292: H1139-H1147
125. Palmer JN Hartogensis WE Patten M Fortuin FD Long CS. Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 1995;95:2555-2564
126. Siwik DA Chang DL Colucci WS. Interleukin-1beta and tumor necrosis factor-Alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000;86:1259-1265
127. Xie Z Singh M Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem 2004;279:39513-39519
128. NishikawaK Yoshida M Kusuhara M Ishigami N Isoda K Miyazaki K et al. Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. Am J Physiol Heart Circ Physiol 2006;291:H176-H183
129. Sanada S Hakuno D Higgins LJ Schreiter ER McKenzie AN Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-1549
130. Demyanets S Kaun C Pentz R Krychtiuk KA Rauscher S Pfaffenberger S et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol 2013;60: 16-26
131. Weinberg EO Shimpo MDeKeulenaerGW MacGillivrayC Tominaga S Solomon SD et al. Expression and regulation of ST2 an interleukin-1 receptor family member in cardiomyocytes and myocardial infarction. Circulation 2002;106:2961-2966
132. Zhu J CarverW. Effects of interleukin-33 on cardiac fibroblast gene expression and activity. Cytokine 2012;58:368-379
133. Gwechenberger M Mendoza LH Youker KA Frangogiannis NG Smith CW Michael LH et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999;99:546-551
134. King KL WinerJ Phillips DMQuach J Williams PM Mather JP. Phenylephrine endothelin prostaglandin F2alpha?. and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro. Endocrine 1998;9:45-55
135. Wollert KC Taga T Saito M Narazaki M Kishimoto T Glembotski CC et al. Cardiotrophin-1 activates a distinct form of cardiacmuscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 1996;271:9535-9545
136. Tsuruda T Jougasaki M Boerrigter G Huntley BK Chen HH DAssoro AB et al. Cardiotrophin-1 stimulation of cardiac fibroblast growth: Roles for glycoprotein 130/ leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res 2002;90:128-134
137. Wang F Trial J Diwan A Gao F Birdsall H Entman Met al. Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor. J Mol Cell Cardiol 2002;34: 1309-1316
138. Feng W Li W Liu W Wang F Li Y Yan W. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp Mol Pathol 2009;87:212-218
139. Madhur MS Lob HE McCann LA Iwakura Y Blinder Y Guzik TJ et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010;55:500-507
140. Baldeviano GCBarin JG TalorMV Srinivasan S Bedja D ZhengDet al. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 2010;106:1646-1655
141. Venkatachalam K Mummidi S Cortez DM Prabhu SD Valente AJ Chandrasekar B. Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2008;294: H2078-H2087
142. Liao YH Xia N Zhou SF Tang TT Yan XX Lv BJ et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 2012;59:420-429
143. Cortez DM Feldman MD Mummidi S Valente AJ Steffensen B Vincenti M et al. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- And ERK1/2-dependent C/EBP-beta NF-kappaB and AP-1 activation. AmJ Physiol Heart Circ Physiol 2007;293:H3356-H3365
144. Bolger AP Sharma R von Haehling S DoehnerW Oliver B RauchhausMet al. Effect of interleukin-10 on the production of tumor necrosis factor-Alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol 2002;90: 384-389
145. Yamaoka M Yamaguchi S OkuyamaM TomoikeH. Anti-inflammatory cytokine profile in human heart failure: Behavior of interleukin-10 in association with tumor necrosis factor-Alpha. Jpn Circ J 1999;63:951-956
146. Hamid T Gu Y Ortines RV Bhattacharya CWang G Xuan YT et al. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation. Circulation 2009;119:1386-1397
147. Verma SK Krishnamurthy P Barefield D Singh N Gupta R Lambers E et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB. Circulation 2012;126:418-429
148. YoshidaT Hanawa H Toba KWatanabe HWatanabe R YoshidaK et al. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc Res 2005;68:278-288
149. Dhingra S Sharma AK Arora RC Slezak J Singal PK. IL-10 attenuates TNF-Alphainduced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 2009;82:59-66
150. Krishnamurthy P Rajasingh J Lambers E Qin G LosordoDW Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 2009;104:e9-18
151. NishikimiTMaeda N Matsuoka H.The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006;69:318-328
152. Ruskoaho H Leskinen H Magga J Taskinen P Mantymaa P Vuolteenaho O et al. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: Role of endothelin nitric oxide and angiotensin II. J Mol Med (Berl) 1997;75:876-885
153. Harada M Saito Y Kuwahara K Ogawa E Ishikawa M NakagawaOet al. Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. J Cardiovasc Pharmacol 1998;31(Suppl 1):S357-S359
154. Lin X Hanze J Heese F Sodmann R Lang RE. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 1995;77:750-758
155. Maki T Horio T Yoshihara F Suga S Takeo S MatsuoHet al. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts. Br J Pharmacol 2000;131:1204-1210
156. Glenn DJ Rahmutula D Nishimoto M Liang F Gardner DG. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 2009;84:209-217
157. Oliver PM Fox JE Kim R Rockman HA Kim HS Reddick RL et al. Hypertension cardiac hypertrophy and sudden Death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997;94:14730-14735
158. Mori T Chen YF Feng JA Hayashi T Oparil S Perry GJ. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. Cardiovasc Res 2004;61:771-779
159. Horio T Tokudome T Maki T Yoshihara F Suga S Nishikimi T et al. Gene expression secretion and autocrine action of C-Type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 2003;144:2279-2284
160. Tokudome T Horio T Soeki T Mori K Kishimoto I Suga S et al. Inhibitory effect of C-Type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: Interference between CNP and endothelin-1 signaling pathways. Endocrinology 2004;145: 2131-2140
161. Schmitter D Cotter G Voors AA. Clinical use of novel biomarkers in heart failure: Towards personalized medicine. Heart Fail Rev 2013; [Epub ahead of print].
162. Lasser C Alikhani VS Ekstrom K Eldh M Paredes PT Bossios A et al. Human saliva plasma and breast milk exosomes contain RNA: Uptake by macrophages. J Transl Med 2011;9:9
163. Pegtel DM Cosmopoulos K Thorley-Lawson DA van Eijndhoven MA Hopmans ES Lindenberg JL et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010;107:6328-6333
164. Valadi H Ekstrom K Bossios A Sjostrand M Lee JJ Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-659
165. Gupta SK Bang C Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 2010;3:484-488
166. Hunter MP Ismail N Zhang X Aguda BD Lee EJ Yu L et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008;3:e3694
167. Vickers KC Palmisano BT Shoucri BM Shamburek RD Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-433
168. Zernecke A Bidzhekov K Noels H Shagdarsuren E Gan L Denecke B et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81
169. Arroyo JD Chevillet JR Kroh EM Ruf IK Pritchard CC Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108:5003-5008
170. Wang K Zhang SWeber J Baxter D Galas DJ. Export of microRNAs and microRNAprotective protein by mammalian cells. Nucleic Acids Res 2010;38:7248-7259
171. ChenX Liang H Zhang JZenK ZhangCY. Horizontal transfer of microRNAs: Molecular mechanisms and clinical applications. Protein Cell 2012;3:28-37
172. Hergenreider E Heydt S Treguer K BoettgerT Horrevoets AJ ZeiherAMet al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012;14:249-256
173. Halkein J Tabruyn SP Ricke-Hoch M Haghikia A Nguyen NQ Scherr M et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013;123:2143-2154
174. Widera C Gupta SK Lorenzen JM Bang C Bauersachs J Bethmann K et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51:872-875
175. DAlessandra Y Devanna P Limana F Straino S Di Carlo A Brambilla PG et al. Circulating microRNAs arenewand sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31:2765-2773
176. Matkovich SJ Wang W Tu Y Eschenbacher WH Dorn LE Condorelli G et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 2010;106:166-175
177. Care A Catalucci D Felicetti F Bonci D Addario A Gallo P et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613-618
178. Liu N Bezprozvannaya S Williams AH Qi X Richardson JA Bassel-Duby R et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008;22:3242-3254
179. van Rooij E Olson EN. Searching for miR-Acles in cardiac fibrosis. Circ Res 2009;104: 138-140
180. Castoldi G Di Gioia CR Bombardi C Catalucci D Corradi B Gualazzi MG et al. MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 2012;227:850-856
181. Bang C Batkai S Dangwal S Gupta SK Foinquinos A Holzmann A et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 2014; in press
182. Waldenstrom A Genneback N Hellman U Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE 2012;7: E34653
183. OkadaHTakemuraGKosaiK LiYTakahashiT EsakiMet al. Postinfarction genetherapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 2005;111:2430-2437
184. Pan Z ZhaoW Zhang XWang BWang J Sun X et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/2. Br J Pharmacol 2011;162:688-700
185. Deng YL Xiong XZ Cheng NS. Organ fibrosis inhibited by blocking transforming growth factor-beta signaling via peroxisome proliferator-Activated receptor gamma agonists. Hepatobiliary Pancreat Dis Int 2012;11:467-478
186. Kapoun AM Liang F OYoung GDammDL QuonD WhiteRTet al. B-Type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: Fibrosis myofibroblast conversion proliferation and inflammation. Circ Res 2004;94:453-461
187. van Rooij E Sutherland LB Liu N Williams AH McAnally J GerardRDet al.Asignature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006;103:18255-18260
188. Bonauer A Carmona G Iwasaki M Mione M Koyanagi M Fischer A et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-1713
189. Fiedler J Jazbutyte V Kirchmaier BC Gupta SK Lorenzen J Hartmann D et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011;124: 720-730
190. Hinkel R Penzkofer D Zuhlke S Fischer A Husada W Xu QF et al. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-Animal model. Circulation 2013;128:1066-1075
191. Nana-Sinkam SP Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013;93:98-104
192. Bouchie A. First microRNA mimic enters clinic. Nat Biotechnol 2013;31:577
193. Qiu Z Dai Y. Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 2013;23:347-355
194. Janssen HL ReesinkHW Lawitz EJ Zeuzem S Rodriguez-Torres M Patel K et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013;368:1685-1694
195. Lorenzen JM Martino F Thum T. Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 2012;107:245
196. Hosoda T Zheng H Cabral-da-Silva M Sanada F Ide-Iwata N Ogorek B et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 2011; 123:1287-1296
197. KimHW Haider HK Jiang S Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-Associated protein 2. J Biol Chem 2009;284:33161-33168